|
|
|
Volumn 106, Issue , 2005, Pages 113-134
|
|
Antisense therapy in clinical oncology: preclinical and clinical experiences.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
CYCLIC AMP DEPENDENT PROTEIN KINASE;
DNA METHYLTRANSFERASE;
PRKCA PROTEIN, HUMAN;
PROTEIN BCL 2;
PROTEIN C MYB;
PROTEIN KINASE C;
PROTEIN KINASE C ALPHA;
RAF PROTEIN;
TGFB2 PROTEIN, HUMAN;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
ANIMAL;
CLINICAL TRIAL;
GENETICS;
HUMAN;
LEUKEMIA;
NEOPLASM;
ONCOGENE RAS;
REVIEW;
ANIMALS;
CLINICAL TRIALS;
CYCLIC AMP-DEPENDENT PROTEIN KINASES;
DNA MODIFICATION METHYLASES;
GENES, RAS;
HUMANS;
LEUKEMIA;
NEOPLASMS;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEIN KINASE C;
PROTEIN KINASE C-ALPHA;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PROTO-ONCOGENE PROTEINS C-MYB;
PROTO-ONCOGENE PROTEINS C-RAF;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
|
|
EID: 16544368128
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (78)
|
